Exclusive: Nandini Piramal, Chairperson, Piramal Pharma On Q4 Earnings & Growth Plans For FY25

#nandanipiramal #q4results #q4earnings #q4fy25 #piramalpharma
Piramal Pharma Ltd has announced a significant 102.1% year-on-year (YoY) increase in net profit, reaching ₹101.3 crore for the fourth quarter ending March 31, 2024. In comparison, the corresponding quarter saw a net profit of ₹50.1 crore, as per the company's regulatory filing. The company's revenue from operations also saw a notable 18% rise, reaching ₹2,552.4 crore compared to ₹2,163.6 crore in the same period of the previous fiscal year. Additionally, at the operating level, EBITDA surged by 50.9% to ₹529.9 crore in this fiscal quarter, up from ₹351.2 crore in the corresponding period of the preceding fiscal year. Nandini Piramal, Chairperson of Piramal Pharma, discusses the Q4 figures and outlines growth strategies for FY25 in an exclusive interview with Business Today's Sakshi Batra.
-----------------------
Thank You for watching! Do not forget to Like | Comment | Share
-----------------------
About the channel
Watch us for the best news and views on business, stock markets, crypto currencies, consumer technology, the world of real estate, bullion, automobiles, start-ups and unicorns and personal finance. Business Today TV will also bring you all you need to know about mutual funds, insurance, loans and pension plans among others.
Follow us at:
Website: https://www.businesstoday.in
WhatsApp: whatsapp.com/channel/0029Va4Hd309hXFCqY62yD2I
Facebook:   / businesstoday  
twitter:   / business_today  
Instagram:   / business_today